IDH1 mutation resulted in significantly shorter survival time in subcutaneous tumor model with CT26 colon cancer tumor, and significantly longer survival time in orthotopic tumor model with GL261 glioma tumor. Here, IDH1 is linked to malignant colon neoplasm.